Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden

類似資料

• Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy
  著者:: Kumar, Nathella Pavan, 等
  出版事項: (2019)
• Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis – Diabetes co-morbidity
  著者:: Kumar, Nathella Pavan, 等
  出版事項: (2021)
• Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment
  著者:: Kumar, Nathella P., 等
  出版事項: (2018)
• Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co‐morbidity
  著者:: Kumar, Nathella P., 等
  出版事項: (2018)
• Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment
  著者:: Kumar, Nathella Pavan, 等
  出版事項: (2016)